HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N- (2,6- dimethylergoline- 8- yl)- 2,2- dimethylpropanamide
structure given in first source; RN given refers to cpd with unknown MF
Also Known As:
SDZ 208-911; SDZ-208-911
Networked:
2
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Alkaloids: 5398
Ergot Alkaloids: 208
Ergolines: 109
N-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide: 2
Fused-Ring Heterocyclic Compounds
4 or More Rings Heterocyclic Compounds
Ergolines: 109
N-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide: 2
Related Diseases
1.
Schizophrenia (Dementia Praecox)
01/01/1990 - "
SDZ 208-911 and SDZ 208-912 could be effective against both the positive and negative symptoms of schizophrenia, while exhibiting a reduced incidence of dystonic and parkinsonian side-effects.
"
2.
Hyperprolactinemia
05/18/1994 - "
The aminoergolines SDZ-208-911, -208-912, and -212-327, weak partial D2 agonists with agonist/antagonist properties, are proposed as potential atypical antipsychotic agents with limited risk of extrapyramidal effects or hyperprolactinemia.
"
Related Drugs and Biologics
1.
N- (2- chloro- 6- methylergoline- 8- yl)- 2,2- dimethylpropanamide
2.
Antipsychotic Agents (Antipsychotics)